AVPAX
Price
$26.98
Change
-$0.16 (-0.59%)
Updated
Jun 23 closing price
Net Assets
3.81B
SSGSX
Price
$52.52
Change
-$0.29 (-0.55%)
Updated
Jun 23 closing price
Net Assets
4.67B
Interact to see
Advertisement

AVPAX vs SSGSX

AVPAX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
AVPAX vs. SSGSX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVPAX is a StrongBuy and SSGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.67B vs. AVPAX (3.81B). AVPAX pays higher dividends than SSGSX: AVPAX (0.73) vs SSGSX (0.54). AVPAX was incepted earlier than SSGSX: AVPAX (27 years) vs SSGSX (27 years). SSGSX (1.23) is less costly to investors than AVPAX (1.16). AVPAX is a more actively managed with annual turnover of: 75.00 vs. SSGSX (50.00). AVPAX (2500) and SSGSX (2500) have matching initial minimum investment requirements. AVPAX annual gain was more profitable for investors over the last year : 26.09 vs. SSGSX (23.02). SSGSX return over 5 years is better than : -3.49 vs. AVPAX (-5.88).
AVPAXSSGSXAVPAX / SSGSX
Total Expense Ratio1.161.2394%
Annual Report Gross Expense Ratio1.161.2394%
Fund Existence27 years27 years-
Gain YTD23.93218.170132%
Front LoadN/A6%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.81B4.67B82%
Annual Yield % from dividends0.730.54135%
Returns for 1 year26.0923.02113%
Returns for 3 years29.5217.95164%
Returns for 5 years-5.88-3.49169%
Returns for 10 years29.2248.5360%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELVN48.552.59
+5.64%
Enliven Therapeutics
SXC8.37N/A
N/A
Suncoke Energy
GNLX2.92N/A
N/A
Genelux Corp
AFRM71.83-0.37
-0.51%
Affirm Holdings
NCNA1.72-0.11
-6.01%
NuCana plc